ProKidney
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ProKidney and other ETFs, options, and stocks.About PROK
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD.
PROK Key Statistics
Stock Snapshot
With a market cap of 664.84M, ProKidney(PROK) trades at $2.28. The stock has a price-to-earnings ratio of -3.82.
On 2025-12-16, ProKidney(PROK) stock traded between a low of $2.10 and a high of $2.30. Shares are currently priced at $2.28, which is +8.6% above the low and -0.9% below the high.
The ProKidney(PROK)'s current trading volume is 2.01M, compared to an average daily volume of 1.15M.
During the past year, ProKidney(PROK) stock moved between $0.46 at its lowest and $7.13 at its peak.
During the past year, ProKidney(PROK) stock moved between $0.46 at its lowest and $7.13 at its peak.
PROK News
H.C. Wainwright analyst Joseph Pantginis initiated coverage of ProKidney (PROK) with a Buy rating and $12 price target The company is pioneering an approach to...